India's Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has laun...
Japan-based medtech company Olympus Corporation has signed a partnership with Revival Healthcare Capital to advance endo...
MilliporeSigma, the US and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technol...
Day 2 of BIO Asia–Taiwan 2025 unfolded with palpable energy and a heightened sense of purpose as stakeholders from...
Bora Health, subsidiary of SunWay Biotech which focuses on pharmaceutical distribution and sales in Taiwan, has entered ...
Japan-based Eisai Co. and Kyorin Pharmaceutical Co. have announced that Eisai (Thailand) Marketing Co., a subsidiary of ...
Cenra Healthcare, the sales and marketing arm of Cenra Inc., has announced the deepening of its long-standing collaborat...
AstraZeneca has announced $50 billion of investment in the United States by 2030, building on America’s global lea...
Chengdu Kanghua Biological Products Co. has announced that Shanghai Healthcare M&A Fund intends to acquire the compa...
Health2Sync, Asia's leading digital chronic disease management platform, has announced the successful integration of Sma...
Inocras Inc., a global leader in whole-genome sequencing (WGS) and bioinformatics, has announced the signing of a Memora...
WuXi XDC Cayman Inc. a leading global Contract Research, Development and Manufacturing Organisation (CRDMO) focused on t...
Cell and gene therapies are reshaping the landscape of modern medicine—but bringing these transformative treatment...
BioSpectrum Asia spoke to Dr Peter Fedichev, CEO of Gero, who explains how ProtoBind-Diff is transforming drug discovery...
South Korea-based Seegene Inc., a global leader in molecular diagnostics (MDx) solutions, has announced the launch of ST...
WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRDMO) in China, has an...
It’s universally acknowledged that Asia-Pacific (APAC) is a hotbed for clinical trials, with multiple reports conf...
Neurizon Therapeutics, a clinical-stage biotech company based in Australia, has announced the development of a new oral ...
